UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSCS
7176
First Trust SMID Capital Strength ETF
FSCS
$59.2M
| $58.8K | ﹤0.01% |
+1,660
| New | +$60.4K |
|
|
CPTN
7177
DELISTED
Cepton, Inc. Common Stock
CPTN
| $58.8K | ﹤0.01% |
18,026
+16,234
| +906% | +$51.4K |
|
7178
Invesco S&P SmallCap Utilities & Communication Services ETF
PSCU
$17.5M
| $58.8K | ﹤0.01% |
991
-1,137
| -53% | -$70.2K |
|
7179
Netcapital
NCPL
$3.23M
| $58.7K | ﹤0.01% |
28,220
+27,817
| +6,902% | +$49.5K |
|
|
TTOO
7180
DELISTED
T2 Biosystems, Inc
TTOO
| $58.5K | ﹤0.01% |
139,240
+139,239
| +13,923,900% | +$116K |
|
7181
TrueShares Structured Outcome August ETF
AUGZ
$43.7M
| $58.4K | ﹤0.01% |
1,514
-3,418
| -69% | -$138K |
|
|
LND
7182
BrasilAgro
LND
$359M
| $58.3K | ﹤0.01% |
+16,150
| New | +$66.5K |
|
|
CMLS
7183
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $58.3K | ﹤0.01% |
86,986
+7,267
| +9% | +$6.87K |
|
7184
CapForce IBD 50 ETF
FFTY
$79.1M
| $58.2K | ﹤0.01% |
2,037
-1,124
| -36% | -$32.7K |
|
7185
Cenntro
CENN
$8.33M
| $58.2K | ﹤0.01% |
907
+901
| +15,017% | +$65.4K |
|
7186
Franklin Responsibly Sourced Gold ETF
FGDL
$448M
| $58.2K | ﹤0.01% |
+1,659
| New | +$59.1K |
|
7187
Fenbo Holdings
FEBO
$8.85M
| $58K | ﹤0.01% |
33,354
+18,454
| +124% | +$52.7K |
|
7188
Shengfeng Development Ltd
SFWL
$69.3M
| $58K | ﹤0.01% |
53,731
+37,155
| +224% | +$45.6K |
|
|
DMRA
7189
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.83B
| $58K | ﹤0.01% |
12,467
+7,368
| +144% | +$48.2K |
|
|
YALA
7190
Yalla Group
YALA
$827M
| $57.7K | ﹤0.01% |
14,224
+13,103
| +1,169% | +$56.3K |
|
7191
Strawberry Fields REIT
STRW
$190M
| $57.7K | ﹤0.01% |
5,478
+2,390
| +77% | +$27.7K |
|
|
MDV
7192
Modiv Industrial
MDV
$186M
| $57.7K | ﹤0.01% |
3,880
-8,488
| -69% | -$138K |
|
7193
LiveOne
LVO
$58.4M
| $57.7K | ﹤0.01% |
3,927
+402
| +11% | +$3.51K |
|
|
DCX
7194
Digital Currency X Technology Inc
DCX
$341M
| $57.6K | ﹤0.01% |
21
+1
| +5% | +$2.51K |
|
|
XNET
7195
Xunlei
XNET
$327M
| $57.6K | ﹤0.01% |
28,944
+16,247
| +128% | +$33K |
|
|
TLX
7196
Telix Pharmaceuticals
TLX
$3.9B
| $57.4K | ﹤0.01% |
+3,730
| New | +$58.6K |
|
7197
Global X S&P 500 Quality Dividend ETF
QDIV
$30.5M
| $57.3K | ﹤0.01% |
1,652
-1,914
| -54% | -$68.9K |
|
|
WBND
7198
DELISTED
Western Asset Total Return ETF
WBND
| $57.1K | ﹤0.01% |
2,926
+2,350
| +408% | +$47.1K |
|
|
CBIO
7199
Crescent Biopharma
CBIO
$617M
| $57K | ﹤0.01% |
2,289
+1,605
| +235% | +$43.8K |
|
7200
Ellomay Capital Ltd
ELLO
$272M
| $56.9K | ﹤0.01% |
+3,501
| New | +$50.9K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.